BIOCYTOGEN-B(02315),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02315 BIOCYTOGEN-B

Trading 06-02 14:53:44

42.300

-2.400

-5.37%

High46.000	Low42.020	Vol1.15M
Open46.000	D1 Closing44.700	Amplitude8.90%
Mkt Cap18.91B	Tradable Cap4.70B	Total Shares447.00M
T/O49.42M	T/O Rate1.03%	Tradable Shares111.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"BIOCYTOGEN-B","latestPrice":42.3,"timestamp":1780383224484,"preClose":44.7,"halted":0,"volume":1148794,"delay":0,"changeRate":-0.05369127516778536,"floatShares":111000000,"shares":447000000,"eps":0.43,"marketStatus":"Trading","change":-2.4,"latestTime":"06-02 14:53:44","open":46,"high":46,"low":42.02,"amount":49419327,"amplitude":0.089038,"askPrice":42.38,"askSize":500,"bidPrice":42.24,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":0.736,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1780387800000},"marketStatusCode":2,"adr":0,"listingDate":1661961600000,"exchange":"SEHK","adjPreClose":44.7,"openAndCloseTimeList":[[1780363800000,1780372800000],[1780376400000,1780387200000]],"volumeRatio":0.900478,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688796","market":"SH","secType":"STK","nameCN":"Biocytogen Pharmaceuticals (Beijing) Co.,Ltd.","latestPrice":96.97,"timestamp":1780383221000,"preClose":100,"halted":0,"volume":1356300,"delay":0,"premium":"-62.38"}},"requestUrl":"/m/hq/s/02315","defaultTab":"news","newsList":[{"id":"1146835875","title":"Biocytogen Updates Articles of Association: 446.90 Million Shares, 9-Member Board and Minimum 10% Cash Dividend Policy","url":"https://stock-news.laohu8.com/highlight/detail?id=1146835875","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146835875?lang=en_us&edition=fundamental","pubTime":"2026-05-21 22:22","pubTimestamp":1779373367,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. released its revised Articles of Association (effective May 2026), setting out comprehensive rules for capital structure, corporate governance, profit...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118832957","title":"BIOCYTOGEN-B Surges Over 6% in Early Trading as RenBiologics Unit Enters Commercialization Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=1118832957","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118832957?lang=en_us&edition=fundamental","pubTime":"2026-05-20 11:14","pubTimestamp":1779246880,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) rose more than 6% in early trading. As of press time, the stock was up 6.03% to HK$50.85, with a turnover of HK$42.8952 million. The company recently participated in the AACR...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","688796","BK4588","BK1161","02315","VXUS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635214982","title":"Asian Stocks Estimated To Be Trading Below Fair Value In May 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635214982","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635214982?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:04","pubTimestamp":1778623461,"startTime":"0","endTime":"0","summary":"As of May 2026, Asian markets have shown resilience with Chinese equities advancing and Japan's indices reaching record highs, driven by strong domestic demand and optimism in technology sectors. In this environment, identifying undervalued stocks can be an attractive strategy for investors seeking opportunities where market prices may not fully reflect a company's intrinsic value.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/8212000-choice1-main-header/1585186704996","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8212000-choice1-main-header/1585186704996"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/semiconductors/hkg-6865/flat-glass-group-shares/news/asian-stocks-estimated-to-be-trading-below-fair-value-in-may","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/semiconductors/hkg-6865/flat-glass-group-shares/news/asian-stocks-estimated-to-be-trading-below-fair-value-in-may","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK6018","ITS.SI","02315","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143907967","title":"BIOCYTOGEN-B Shares Surge Over 6% in Afternoon Trading on Announcement of Major Project Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=1143907967","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143907967?lang=en_us&edition=fundamental","pubTime":"2026-05-12 14:00","pubTimestamp":1778565628,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) saw its shares rise more than 6% in afternoon trading. At the time of writing, the stock was up 6.2%, trading at HK$54.8 with a turnover of HK$48.46 million. The increase follows...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","VXUS","BK4585","BK0216","688796","02315","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159470505","title":"Biocytogen-B Shares Surge Over 9% as First-Quarter Net Profit Soars Nearly Ninefold to RMB104 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1159470505","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159470505?lang=en_us&edition=fundamental","pubTime":"2026-04-28 10:02","pubTimestamp":1777341731,"startTime":"0","endTime":"0","summary":"Biocytogen-B (02315) saw its shares rise more than 9% during the trading session. By the time of writing, the gain had narrowed slightly to a modest increase of 1.61%, with the share price currently...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688796","BK1161","02315","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150363873","title":"Stock Track | BIOCYTOGEN-B Soars 9.18% in Early Trading on Strong Q1 Earnings and Major R&D Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=1150363873","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150363873?lang=en_us&edition=fundamental","pubTime":"2026-04-28 09:59","pubTimestamp":1777341555,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B's stock price soared 9.18% during early trading on Tuesday, reflecting strong investor sentiment towards the company.The surge follows the release of the company's first-quarter 2026...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133299273","title":"BIOCYTOGEN-B Shares Surge Over 9% in Morning Session on Strong Q1 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1133299273","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133299273?lang=en_us&edition=fundamental","pubTime":"2026-04-28 09:57","pubTimestamp":1777341425,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) rose more than 9% during early trading. At the time of writing, the stock was up 7.65% to HK$63.35, with a turnover of HK$54.1856 million. The company reported its first-quarter...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK0216","BK4588","688796","BK1161","02315","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630952803","title":"Biocytogen Pharmaceuticals Turns to Profit in Q1","url":"https://stock-news.laohu8.com/highlight/detail?id=2630952803","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630952803?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:45","pubTimestamp":1777290344,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals   recorded an attributable profit of 104 million yuan in the first quarter of 2026, compared with an attributable loss of 13.2 million yuan a year prior, according to a Monday Hong Kong bourse filing.Earnings per share stood at 0.23 yuan, compared with a loss per share of 0.03 yuan in the corresponding period of the previous fiscal year.Operating revenue jumped 74% in the three months to 433.1 million yuan from 249.3 million yuan in the year-ago period, driven by a substantially higher revenue contribution from pharmacology and efficacy services and animal models.The pharmaceutical company attributed the higher profit mainly to revenue growth and improved operating efficiency amid expense management.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106583514","title":"BIOCYTOGEN-B Reports Q1 Profit Turnaround with 104 Million Yuan Net Income","url":"https://stock-news.laohu8.com/highlight/detail?id=1106583514","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106583514?lang=en_us&edition=fundamental","pubTime":"2026-04-27 16:38","pubTimestamp":1777279108,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) announced its first-quarter results for the three months ended March 31, 2026. The group recorded revenue of 433 million yuan, representing a 73.68% increase year-over-year. Net...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315","BK1161","688796","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174628270","title":"BIOCYTOGEN-B Shares Surge Over 4% in Morning Session on Explosive 2025 Profit Growth and BD Licensing Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1174628270","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174628270?lang=en_us&edition=fundamental","pubTime":"2026-04-24 10:44","pubTimestamp":1776998660,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) rose more than 4% during morning trading. At the time of writing, the stock was up 4.1% to HK$59.6, with a turnover of HK$26.46 million. The increase follows the company's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688796","BK1161","02315","VXUS","BK4585","BK4588","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194243065","title":"Biocytogen Sets 21 May 2026 AGM: No 2025 Dividend, Seeks RMB1.00 B Credit Line and Capital Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=1194243065","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194243065?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:03","pubTimestamp":1776949410,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. has released its AGM circular, outlining key resolutions to be tabled on 21 May 2026. • 2025 Operating Highlights    – Revenue: RMB1.38 billion, up...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149536872","title":"Biocytogen Sets 21 May 2026 for 2025 AGM; Agenda Covers Profit Distribution, Capital Increase and Credit Facilities","url":"https://stock-news.laohu8.com/highlight/detail?id=1149536872","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149536872?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:03","pubTimestamp":1776949389,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) will convene its 2025 Annual General Meeting (AGM) at 14:00 on 21 May 2026. Shareholders may participate in person at 12 Baoshen South...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101603707","title":"百奥赛图2025年收入突破13亿元，净利润同比大增逾四倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1101603707","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101603707?lang=en_us&edition=fundamental","pubTime":"2026-04-21 16:48","pubTimestamp":1776761298,"startTime":"0","endTime":"0","summary":"百奥赛图（北京）股份有限公司（以下简称“公司”）于2025年度实现经营业绩的显著提升：全年收入约人民币13.788亿元，同比增长40.6%，净利润约人民币1.732亿元，同比增幅达416.4%。公司管理层在年内完成了A股发行并于2025年12月10日登陆科创板，与早前在香港联交所（股票代码：02315）上市的H股形成双上市架构，监督职能由上市后设立的审计委员会承担，原有监事会相应撤销。...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"百奥赛图2025年收入突破13亿元，净利润同比大增逾四倍","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186905580","title":"Biocytogen releases 2025 ESG report: RMB 1.38 billion revenue, 31.8% R&D ratio and 17,418 tCO₂e emissions disclosed","url":"https://stock-news.laohu8.com/highlight/detail?id=1186905580","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186905580?lang=en_us&edition=fundamental","pubTime":"2026-04-21 16:44","pubTimestamp":1776761061,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. published its 2025 Environmental, Social and Governance (ESG) report, detailing financial and non-financial performance across its A- and H-share...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163440681","title":"Biocytogen Schedules 27 April Board Meeting to Approve Q1 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1163440681","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163440681?lang=en_us&edition=fundamental","pubTime":"2026-04-15 17:21","pubTimestamp":1776244864,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced that its Board of Directors will convene on Monday, 27 April 2026. The primary agenda is to review and approve the consolidated financial...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152234148","title":"Pharmaceutical Innovation Sector Gains Policy Support as State Council Issues Guidelines on Drug Pricing Mechanisms (With Relevant Stocks)","url":"https://stock-news.laohu8.com/highlight/detail?id=1152234148","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152234148?lang=en_us&edition=fundamental","pubTime":"2026-04-15 07:24","pubTimestamp":1776209091,"startTime":"0","endTime":"0","summary":"A new policy document issued by the State Council aims to improve the market-based drug pricing mechanism, with significant positive implications for the innovative drug sector. The guidelines...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456846285.SGD","LU0588546209.SGD","BK1161","LU0819121731.USD","VXUS","BK4585","LU0140636845.USD","BK1574","SG9999002562.SGD","LU0516423174.USD","02315","LU0417516902.SGD","BK1583","BK1610","LU0326950275.SGD","LU2242644610.SGD","LU2045819591.USD","BK1141","LU0359201612.USD","LU3063872942.SGD","BK4588","LU0359202008.SGD","02359","LU0327786744.USD","LU0307460666.USD","LU1242518931.SGD","LU1794554557.SGD","159992","LU0572944931.SGD","SG9999002463.SGD","BK1589","LU1688375341.USD","LU2039709279.SGD","06978","LU0181495838.USD","LU0348825331.USD","LU2125910500.SGD","LU0516422366.SGD","LU0348735423.USD","IE00B0JY6N72.USD","LU0856984785.SGD","03347","LU0039217434.USD","LU0456827905.SGD","LU1880383366.USD","LU0051755006.USD","LU0417516738.SGD","LU0708995583.HKD","LU0516422440.USD","LU0043850808.USD","LU1242518857.USD","LU0823426480.USD","LU0516423091.SGD","BK1521","LU0823426308.USD","LU0979878070.USD","02269","06127","LU1046422090.SGD","BK1576","LU1720050803.USD","LU0320764599.SGD","LU0052750758.USD","LU0516422952.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131091280","title":"BIOCYTOGEN-B Shares Surge Over 7% in Late Trading as AI System Poised to Accelerate \"Thousand Mice Ten Thousand Antibodies\" Program","url":"https://stock-news.laohu8.com/highlight/detail?id=1131091280","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131091280?lang=en_us&edition=fundamental","pubTime":"2026-04-14 15:18","pubTimestamp":1776151112,"startTime":"0","endTime":"0","summary":"BIOCYTOGEN-B (02315) saw its shares rise more than 7% in late trading. At the time of writing, the stock was up 7.06% to HK$61, with a turnover of HK$114 million. On the news front, on April 9,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02315","BK4588","BK0216","688796","AGIX","AIPO","CHAT","BK4585","VXUS","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624663980","title":"Asian Growth Companies With High Insider Ownership In April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2624663980","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624663980?lang=en_us&edition=fundamental","pubTime":"2026-04-03 06:08","pubTimestamp":1775167686,"startTime":"0","endTime":"0","summary":"As geopolitical tensions and energy market volatility dominate the global landscape, Asian markets have been navigating these challenges with a focus on resilience and growth. Amidst this backdrop, companies in Asia with high insider ownership are often seen as attractive prospects due to their potential for aligned interests between management and shareholders, offering a unique perspective in times of uncertainty.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9621091-choice2-main-header/1585186855318","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9621091-choice2-main-header/1585186855318"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/automobiles/hkg-2889/pateo-connect-technology-shanghai-shares/news/asian-growth-companies-with-high-insider-ownership-in-april-4","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/automobiles/hkg-2889/pateo-connect-technology-shanghai-shares/news/asian-growth-companies-with-high-insider-ownership-in-april-4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199722588","title":"Biocytogen-B Shares Surge Over 5% in Morning Session Following Formal Strategic Partnership Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=1199722588","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199722588?lang=en_us&edition=fundamental","pubTime":"2026-04-02 11:40","pubTimestamp":1775101239,"startTime":"0","endTime":"0","summary":"Biocytogen-B (02315) saw its shares rise more than 6% during the trading session. At the time of writing, the stock was up 5.29%, trading at HK$62.70, with a turnover of HK$56.9547 million. Sihuan...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK0216","02315","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141444588","title":"Biocytogen-B Shares Extend Rally with Over 6% Gain on AI-Driven Obesity Drug Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=1141444588","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141444588?lang=en_us&edition=fundamental","pubTime":"2026-04-02 11:36","pubTimestamp":1775100980,"startTime":"0","endTime":"0","summary":"Biocytogen-B (02315) rose more than 6% again, reaching HK$63.3 at the time of writing, with a trading volume of HK$56.0117 million. The increase follows the announcement of a formal strategic...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK1574","159992","688796","BK1600","BK4585","CHAT","AIPO","AGIX","00460","BK1593","02315","BK0216","BK1515","BK4588","BK1161","BK1191","06978"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":-0.1035},{"period":"1month","weight":-0.1469},{"period":"3month","weight":-0.0325},{"period":"6month","weight":0.4522},{"period":"1year","weight":1.5112},{"period":"ytd","weight":0.2663}],"compareEarnings":[{"period":"1week","weight":-0.0081},{"period":"1month","weight":-0.0147},{"period":"3month","weight":-0.0144},{"period":"6month","weight":-0.0141},{"period":"1year","weight":0.0905},{"period":"ytd","weight":-0.0091}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Biocytogen Pharmaceuticals (Beijing) Co Ltd is a China-based company primarily engaged in the provision of innovative animal models and pre-clinical pharmaceutical research and development services based on its independently developed gene-editing technology. The Company utilizes its self-developed RenMice fully human antibody and T-cell receptor (TCR) mouse platform for large-scale drug discovery and development targeting potential drug targets in the human body. The Company’s main businesses include the sale of innovative animal models, pre-clinical pharmacology and efficacy evaluation services, and antibody development. The Company is also engaged in the provision of gene-editing services. The Company operates its businesses in the domestic market and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.018702},{"month":2,"riseRate":0.75,"avgChangeRate":0.087225},{"month":3,"riseRate":0.5,"avgChangeRate":0.15364},{"month":4,"riseRate":0.25,"avgChangeRate":-0.063264},{"month":5,"riseRate":0.5,"avgChangeRate":0.097922},{"month":6,"riseRate":0.25,"avgChangeRate":-0.015464},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.033427},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.055975},{"month":9,"riseRate":0.666667,"avgChangeRate":0.092895},{"month":10,"riseRate":0.25,"avgChangeRate":-0.096483},{"month":11,"riseRate":0.5,"avgChangeRate":0.009059},{"month":12,"riseRate":0.5,"avgChangeRate":0.137663}],"exchange":"SEHK","name":"BIOCYTOGEN-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BIOCYTOGEN-B(02315),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BIOCYTOGEN-B(02315) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BIOCYTOGEN-B,02315,BIOCYTOGEN-B股票,BIOCYTOGEN-B股票老虎,BIOCYTOGEN-B股票老虎国际,BIOCYTOGEN-B行情,BIOCYTOGEN-B股票行情,BIOCYTOGEN-B股价,BIOCYTOGEN-B股市,BIOCYTOGEN-B股票价格,BIOCYTOGEN-B股票交易,BIOCYTOGEN-B股票购买,BIOCYTOGEN-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BIOCYTOGEN-B(02315),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BIOCYTOGEN-B(02315) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}